🌟 Value Recognition Spotlight: Patients First🌟 We are excited to recognize Annabel Lunn for embodying the value of Patients First at Nevro. Her dedication and commitment to this value have made a significant impact on our team and organization. Annabel's actions reflect our core values and inspire us all to strive for excellence. Join us in celebrating her outstanding contributions to our team and culture! #TeamNevro #NevroAchievers #EmployeeRecognition #PatientsFirst
Nevro
Medical Equipment Manufacturing
Redwood City, California 64,308 followers
We Believe True Innovation Transforms More Lives
About us
Nevro is a global medical device company focused on delivering innovation to improve the quality of life for patients suffering from debilitating chronic pain. Through Nevro's pain management solutions, Nevro | HFX and Nevro | SI Joint, Nevro brings together enduring technologies, optimized therapies, and individualized patient support, all built on a foundation of proof that results in a comprehensive solution to relieve the burden of pain for more patients. HFX is a comprehensive solution that includes a Senza Spinal Cord Stimulation system and support services for the treatment of chronic pain, including painful diabetic neuropathy when programmed with a frequency of 10 kHz. Nevro | SI Joint includes the Nevro1™ SI joint fusion system with integrated transfixing technology provides immediate stabilization with opportunity for long-term fusion and pain relief through a posterior minimally invasive surgical (MIS) approach.
- Website
-
https://www.nevro.com
External link for Nevro
- Industry
- Medical Equipment Manufacturing
- Company size
- 1,001-5,000 employees
- Headquarters
- Redwood City, California
- Type
- Public Company
- Founded
- 2006
Locations
-
Primary
1800 Bridge Parkway
Redwood City, California 94065, US
Employees at Nevro
Updates
-
Last week, as part of their onboarding training, we welcomed our newest Sales Representatives to headquarters in Redwood City. We’re excited to welcome Foundational Class 79 📚 🎓 ! Get ready to watch them transform lives - one patient at a time. #Nevro #TeamTraining #SalesExcellenceAcademy #SaleExcellence #NevroHFX #NevroSIJ John Logeman Heather Steffen Jordonna Asbridge
-
-
Nevro reposted this
#NSANZ2024 is underway here in Hobart, Tasmania!!! 🇦🇺 With almost 12 years in the market we couldn’t be prouder to be showcasing long term evidence & durability of our #HFXSCS therapy! Great start here with team mates & friends from across the globe 🌎 #Nevro #Neuromodulation #NSANZ #LongTermData
-
-
Nevro reposted this
The latest insights on kHz SCS from Nevro’s Scientific Research team was just published in Biomedicines https://lnkd.in/gqFMKMNe . This work, "Frequency-Dependent Neural Modulation of Dorsal Horn Neurons by Kilohertz Spinal Cord Stimulation in Rats," used Calcium imaging in an in vitro slice model to investigate neuronal activity at different depths of rodent dorsal horn in response to extracellular kHz spinal cord stimulation. The key observations are that the strength of the response is positively and monotonically correlated to frequency, in that the maximum effects were seen using 8 kHz – 10 kHz; these responses were approximately 2-fold those seen at 1 kHz. This higher kHz frequency dominance was also observed at deeper dorsal horn regions. Finally, and perhaps most interestingly, individual neurons appeared to have a particular frequency which maximized their Calcium fluorescent response; in fact, 8 kHz was the optimal frequency for a substantial number of neurons (25-40% of population). This seminal work may improve how high kHz frequency is applied clinically. Congratulations to the team of Dong Wang, who played a key role in the conceptualization of the experiments and manuscripts and is a leading researcher in kHz stimulation; Kwan Yeop Lee, who has visionarily conceived and performed the core experiments providing the base understanding of direct & selective activation of inhibitory neurons in the dorsal horn via low-intensity kHz SCS; Dongchul Lee, a pioneer in SCS computational modeling and broad- and deep-thinking leader of exploratory work studying mechanisms of kHz stimulation, and Zack Kagan, a critical and analytical contributor to studies of kHz SCS, as well as a key clinical and educational liaison, fostering translation from animal-to-bedside and communication with physicians of the merits and mechanisms of kHz SCS.
-
It was an unforgettable weekend in Miami at #ASPN2024! A sincere thank you to the American Society of Pain and Neuroscience ASPN for bringing together thought leaders and innovators from across the globe. Thank you to everyone who stopped by the Nevro booth or attended one of our customer dinners to learn more about Nevro and our AI-driven SCS Innovations & Comprehensive SI Joint Solutions. We are grateful for our physician and APP partners whose support drives our mission forward. A special thank you to Drs. Ashley Bailey-Classen, DO, Alexander Escobar, M.D., Warren Grace III, M.D., Kristen Klein NP, and Dr. Usman Latif, for your partnership and education on behalf of Nevro. Nevro appreciates the opportunity to participate in the ASPN annual conference, and we look forward to the next one! #NevroHFXiQ #NevroSIJoint
-
-
New publication alert! David Provenzano and Jozef Leech ’s innovative analysis was recently published in Neuromodulation, “Defining Short- and Long-Term Programming Requirements in Patients Treated With 10-kHz Spinal Cord Stimulation”. This study tells: “To our knowledge, this study is the first real-world, single-center study to provide a detailed, longitudinal view of 10-kHz SCS programming; 10-kHz SCS is an effective therapy for the treatment of chronic pain, with a high responder rate achieved with minimal required Device Programming during both trial and post permanent implant phase” Read the full study here: https://lnkd.in/grc3numA
Defining Short- and Long-Term Programming Requirements in Patients Treated With 10-kHz Spinal Cord Stimulation
sciencedirect.com
-
Recently, our US Sales Excellence team got together to strengthen team culture and re-brand the team’s efforts, programs, and support roles. This led to a workshop on accelerating the strategic learning plan to better deliver against the needs of our Nevro US Sales Team, healthcare professional partners, and most importantly the patients we serve. At this meeting they discussed the diverse and unique strengths to achieve unified goals, adult learning & development strategies, and short term & long term evolution of our training programs. Our US Sales Excellence team leads the learning and development effort for all field personnel, from new hire onboarding, to field training, ongoing training initiatives, and our management development program. This year the team has trained over 100 Nevro US Sales team members, so far, either new to role or Nevro. If you’re interested in joining the Nevro Sales Team, and working directly with this team, check out our careers page: https://lnkd.in/g3T4vNAA #Nevro #SalesExcellence #Sales John Logeman Jordonna Asbridge Heather Steffen Daniel Balkcom
-
-
Are you currently in Miami and attending the 6th Annual ASPN conference? Have you checked out our booth yet? Come say hello and see our latest innovations. #NevroHFX #NevroSIJoint #HFXiQ #Nevro1
-
-
Are you planning out your schedule for this weekend's American Society of Pain and Neuroscience ASPN? Please join Dr. Erika Petersen the morning of Sunday, 7/14, to hear her discussion on “Quality-of-life and HbA1c continue to improve at 4 years post-implant in patients with painful diabetic neuropathy treated with 10kHz spinal cord stimulation.” #ASPN2024 #SCS #NevroHFX
-
-
This year at American Society of Pain and Neuroscience ASPN, be sure to check out our latest clinical research and evidence around 10 kHz Therapy™ and Nevro1™ SI Joint fusion technology! #ASPN2024 #SCS #SIJoint
-
Similar pages
Browse jobs
Stock
NVRO
NYSE
20 minutes delay
$9.88
0.14 (1.437%)
- Open
- 9.71
- Low
- 9.71
- High
- 10.29
Data from Refinitiv
See more info on